Obesity (Silver Spring) by Saydah, Sharon et al.
Trends in Cardiovascular Disease Risk Factors by Obesity Level 
in Adults in the United States, NHANES 1999-2010
Sharon Saydah1, Kai McKeever Bullard1, Yiling Chen1, Mohammed K. Ali2, Edward W. 
Gregg1, Linda Geiss1, and Giuseppina Imperatore1
1Centers for Disease Control and Prevention, National Center for Health Promotion and Disease 
Prevention, Division of Diabetes Translation, Hyattsville, MD, USA
2Emory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, 
GA, USA
Abstract
Objective—To assess whether trends in cardiovascular disease (CVD) risk factors by among 
overweight and obese US adults have improved.
Methods—The study included 10,568 adults 18 years and older who participated in National 
Health and Nutrition Examination Survey 1999-2010. CVD risk factors included diabetes (self-
reported diagnosis, glycated hemoglobin ≥6.5%, or fasting plasma glucose ≥126mg/dl), 
hypertension (treatment or blood pressure ≥140/90 mmHg), dyslipidemia (treatment or non-HDL 
cholesterol ≥160 mg/dl), and smoking (self-report or cotinine levels ≥10 ng/ml). The prevalence 
and temporal trends of CVD risk factors for each BMI group were estimated.
Results—In 2007-2010, the prevalence of diabetes, hypertension, and dyslipidemia was highest 
among obese (18.5%, 35.7%, 49.7%, respectively) followed by overweight (8.2%, 26.4%, 44.2%, 
respectively) and normal weight adults (5.4%, 19.8%, 28.6%, respectively). Smoking exposure 
was highest among normal weight (29.8%) followed by overweight (24.8%) and obese adults 
(24.6%). From 1999-2002 to 2007-2010, untreated hypertension decreased among obese and 
overweight adults and untreated dyslipidemia decreased for all weight groups. There were no 
significant temporal changes in smoking across BMI groups.
Conclusions—Despite decreases in untreated risk factors, it is important to improve the CVD 
risk profile of overweight and obese US adults.
Introduction
In 2008-2010, over 35% of adults 18 years and older in the United Stat were obese (1) and 
there is evidence that overweight and obesity among adults is associated with increased risk 
of cardiovascular disease (CVD) (2,3) and an increased risk of diabetes (4). Although there 
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appears to be a leveling off of obesity levels in the United States (1), it is unknown whether 
the health burdens associated with higher weight may be continuing to increase (5).
Using data from national health surveys from 1960 to 2000, Gregg and colleagues (6) 
reported a significant decline in major cardiovascular risk factors, except diabetes, across all 
BMI levels. However, over this time period, the prevalence of undiagnosed diabetes 
decreased, particularly among the highest weight group (7). Whether these trends have 
continued in the past decade is unknown. Therefore, we analyzed data from the National 
Health and Nutrition Examination Survey (NHANES) from 1999 through 2010 to examine 
trends in the prevalence and diagnosis or treatment of cardiovascular risk factors by weight 
status among adults in the United States.
Methods
The NHANES is a cross-sectional survey of the health and nutritional status of the US 
civilian, noninstitutionalized population conducted by the National Center for Health 
Statistics (NCHS), Centers for Disease Control and Prevention (CDC) (8). Participants were 
randomly selected through a complex, multistage cluster sampling probability design. The 
NHANES collects data through interviews in participants' homes and conducts medical 
examinations and laboratory assessments in the Mobile Examination Center. For this report, 
we analyzed 1999-2010 NHANES data on participants who were 18 years or older and had 
complete measurements of CVD risk factors and anthropometry (n = 33,560). NHANES is 
conducted in independent, 2-year cycles. Response rates for participation in both the 
interview and physical examination were similar across cycles and ranged from 75 to 80% 
(9). The survey protocol was approved by the NCHS institutional review board. Written 
informed consent was obtained from all participants aged ≥18 years. NHANES methods and 
protocols for the questionnaires, laboratory, and examination have been described 
extensively (8).
Demographics included age, sex, and race/ethnicity. Race/ethnicity was based on self-report 
and categorized as non-Hispanic white, non-Hispanic black, Mexican American, or Hispanic 
and non-Hispanic other. Family income was included as a percentage of the established 
poverty income ratio (PIR), calculated as the family's income divided by the federal poverty 
level (defined as 100% in the categories below). PIR was categorized as <1.50, 1.50 to 3.50, 
and ≥3.50. Participants were considered to have health insurance if they reported to be 
covered by a health insurance plan at the time of the survey.
BMI groups
Participants were categorized based on BMI group as 18 to <25 kg/m2 (normal weight), 
BMI 25 to <30 kg/m2 (overweight), and BMI ≥ 30 kg/m2 (obese). Participants with BMI ≥ 
35 kg/m2 (morbidly obese) are included in the obese category and presented separately. 
Underweight participants (BMI < 18.5 kg/m2 ) were excluded (n = 606).
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Cardiovascular disease risk factors
Information regarding presence of cardiovascular risk factors was obtained during the 
NHANES interview and examination. Four CVD risk factors were included in the analysis: 
diabetes, hypertension, dyslipidemia, and smoking.
Blood pressure (BP) was measured during the NHANES physical examination in the mobile 
examination center. Up to three BP measurements were taken by a physician after a 5-
minute rest following the NHANES standard protocol and the average of the measurements 
was used for the analysis. Non-HDL cholesterol was used for serum lipid levels and was 
calculated as total cholesterol minus HDL cholesterol.
Hypertension was defined as self-report of use of antihypertensive medications or systolic 
BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg. Among those without self-report of 
antihypertensive medication use, untreated hypertension was defined as systolic BP ≥ 140 
mmHg or diastolic BP ≥ 90 mmHg (10).
Total dyslipidemia was defined as self-report of use of medications to lower cholesterol or 
non-HDL cholesterol ≥ 160 mg/dl. Among adults with no self-report of cholesterol-lowering 
medications, untreated dyslipidemia was defined as non-HDL cholesterol ≥ 160 mg/dl 
(11,12).
Among participants 20 years and older, self-reported smoking was defined as having 
smoked at least 100 cigarettes in a lifetime and report of current smoking. Among 
participants 18 and 19 years old, self-reported smoking was defined as report of use of 
nicotine or tobacco products in the last 5 days. Moderate to heavy smoking exposure was 
defined based on cotinine levels ≥ 10 ng/ml, regardless of self-reported smoking.
Fasting plasma glucose was measured on participants randomly selected for the morning 
exam who reported fasting between 8 and 24 hours (1999-2002, n = 4328; 2003-2006, n = 
4305; 2007-2010, n = 5085). Analysis of diabetes was restricted to this subsample. Total 
diabetes was defined by self-report of diagnosis by health care professional or glycated 
hemoglobin (A1c) level ≥ 6.5% or fasting plasma glucose ≥ 126 mg/dl (13). Among those 
without self-report of diabetes, undiagnosed diabetes was defined as an A1c level ≥ 6.5% or 
fasting plasma glucose ≥ 126 mg/dl. We did not distinguish between type 1 and type 2 
diabetes.
Statistical analysis
Sample design variables and weights were used to produce nationally representative 
estimates that accounted for the NHANES complex survey design, including its stratified 
multistage cluster sampling. We used SAS 9.3 and SUDAAN 11 software (Research 
Triangle Institute, Research Triangle Park, NC) for the statistical analyses.
To assess trends over time and produce reliable estimates, we grouped data into 4-year 
periods: 1999-2002, 2003-2006, 2007-2010 (14). The 4-year time periods were compared 
based on demographics and measures of obesity. Prevalence of each risk factor was 
calculated overall and for each BMI group. We calculated the absolute change in prevalence 
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over a decade as the percent estimate for 2007-2010 minus the percent estimate for 
1999-2002. Among those with a risk factor, the percent undiagnosed or untreated was 
calculated. Among adults who fasted and completed the morning examination, the 
prevalence of adults with 1, 2, or ≥3 risk factors within each BMI group was also calculated. 
As there was little difference between self-reported smoking and moderate to heavy 
smoking exposure based on cotinine, self-reported smoking was included in the count of the 
number of risk factors.
Results were age standardized to the 2000 US census population using the direct method 
with three age groups: 18-44, 45-64, and ≥ 65 years.
Results
Participants' characteristics overall and by survey period are reported in Table 1. Overall, 
there was little change in the demographics from 1999-2002 to 2007-2010. However, over 
this period, the percent of adults 18-44 years decreased (55.2-48.9%), percent of obese 
adults increased (30.1-34.3%), and the percent of morbidly obese adults increased 
(12.4-14.7%).
The age-standardized prevalence of each cardiovascular risk factor for each survey period 
overall and by weight status group is presented in Table 2. In 2007-2010, among normal 
weight adults, the prevalence of total diabetes was 5.4% and the prevalence of total 
hypertension, total dyslipidemia, and total smoking exposure was 19.8%, 28.6%, and 29.8%, 
respectively. Among normal weight adults from 1999-2002 to 2007-2010, there was no 
significant change in the prevalence of total diabetes, hypertension, or smoking exposure.
Among overweight adults, the prevalence of each cardiovascular risk factor, except for 
smoking exposure, was higher than among normal weight adults. In this group, from 
1999-2002 to 2007-2010, there was no significant change in the prevalence of total diabetes, 
hypertension, or smoking exposure, but dyslipidemia decreased significantly (−3.4 
percentage points [ppt], 95% confidence interval [CI] −6.3, −0.5).
In general and throughout the time period, the prevalence of total diabetes, hypertension, 
and dyslipidemia were higher among adults who were obese than those who were 
overweight or normal weight, while smoking exposure (either based on self-report or 
cotinine levels) was lower. Among adults who were obese, there was no significant change 
from 1999-2002 to 2007-2010 for total diabetes, hypertension, dyslipidemia, or total 
smoking exposure. There was also no significant change for undiagnosed diabetes. 
However, there was a significant decrease for untreated hypertension (24.6 ppt, 95% CI 
−7.1, −2.0) and untreated dyslipidemia (−9.6 ppt, 95% CI −12.5, −6.6).
Among the obese adults, those who were morbidly obese (BMI ≥ 35 kg/m2 ) had an even 
higher prevalence of diabetes, hypertension, and dyslipidemia. In this group, there were also 
significant changes between 1999-2002 and 2007-2010 in risk factors for untreated 
hypertension (−4.6 ppt, 95% CI −8.3, −0.8) and dyslipidemia (−6.6 ppt, 95% CI −11.1, 
−2.1).
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Figure 1 presents the proportion of adults with undiagnosed diabetes among total diabetes or 
untreated hypertension among total hypertension or untreated dyslipidemia among total 
dyslipidemia by BMI status across time periods. The proportion of undiagnosed diabetes 
was approximately 30% for all BMI groups and there was not a consistent pattern of 
increase or decrease over time. The proportion of untreated hypertension among adults with 
hypertension and untreated dyslipidemia among adults with dyslipidemia did not change 
among normal weight adults. The proportions of untreated hypertension across weight 
groups decreased from 51 to 39% among overweight adults, from 39.7 to 26.8% among 
obese adults, and from 34 to 21% among morbidly obese adults. The proportions of 
untreated dyslipidemia also decreased for all weight groups with the larger decreases among 
the obese (9.6 ppt) and morbidly obese adults (6.5 ppt).
Table 3 presents the age standardized prevalence for 1, 2, and ≥3risk factors for CVD by 
BMI status. In 2007-2010, adults who were obese had the highest prevalence of ≥3 risk 
factors (13.5%) followed by overweight adults (5.5%) and normal weight adults (3.2%). 
Morbidly obese adults had a 16.5% prevalence of ≥3 CVD risk factors. From 1999-2002 to 
2007-2010, there was no statistically significant change in the prevalence of 1, 2, or ≥3 risk 
factors for normal weight or overweight adults. For the obese and morbidly obese adults, 
there was a significant increase in the prevalence of ≥3 risk factors (3.1 ppt 95% CI 0.5, 5.6, 
and 5.3 ppt 95% CI 0.7, 10.0).
Discussion
The prevalence of cardiovascular risk factors remains high among all adults and increases as 
people become overweight or obese. In 2007-2010, over 18% of obese adults had diabetes, 
36% had hypertension, and 50% had dyslipidemia. With the exception of total smoking 
exposure, the prevalence of cardiovascular risk factors was highest among obese adults 
followed by overweight and normal weight adults. The prevalence of cardiovascular risk 
factors among morbidly obese adults, a subgroup of obese adults, was even higher.
Despite the increase in the prevalence of obese adults in the US population, the prevalence 
of CVD risk factors has remained the same or declined over the past decade. This decline 
continues declines reported since the 1960s (6,15-19). More importantly, the proportion of 
untreated hypertension and untreated dyslipidemia among those with hypertension or 
dyslipidemia declined between 1999-2002 and 2007-2010. Of concern is the finding that 
among overweight or obese people the proportion of undiagnosed diabetes has not changed 
significantly in this time period and it remains similar to previous reports (7).
The decrease in prevalence with untreated hypertension and untreated dyslipidemia may be 
an indication that adults are getting screened and treated for these conditions, regardless of 
weight status. The indication that the decrease is greater among obese adults may indicate 
that these individuals are more likely to be screened and tested for CVD risks. 
Antihypertension medication use has increased in the United States in the past decade 
although control levels are still suboptimal (20). This supports our observation of decrease 
in untreated hypertension over this same time period regardless of weight status. Although 
the prevalence of hypertension differed by weight status, there was no change in the 
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prevalence of hypertension, regardless of weight status. This lack of change in prevalence 
has been reported previously (21). The hypertension definition includes self-report of 
medication use or elevated BP. These results suggest that individuals are more likely to be 
treated for hypertension. This observation may suggest a shift to the left in the BP 
distribution and decrease of BP levels in the US population. Our results with dyslipidemia 
and elevated non-HDL cholesterol correspond to previously reported trends that examined 
the mean levels of lipids among adults in the United States (22). However, obese and 
overweight adults are still twice as likely to have untreated dyslipidemia, highlighting an 
area that could benefit from increased screening and treatment.
Smoking was the one risk factor where the prevalence has not changed significantly in any 
BMI group from 1999-2002 to 2007-2010. For this study, we used both self-report of 
smoking status and serum cotinine levels to estimate smoking exposure. Serum cotinine 
levels are highly correlated with self-report (23). The lower levels of smoking exposure 
among overweight and obese adults may indicate a success of smoking prevention or 
treatment programs among these groups. Reverse causality may also explain this 
relationship as studies have found smoking to be associated with weight loss and smoking 
cessation to be associated with weight gain (24). It is also plausible that the self-report data 
are more susceptible to social desirability bias. However, inclusion of serum cotinine levels 
reduces this possible bias.
In the United States, over 46% of all adults have at least one uncontrolled risk factor for 
CVD (25). We found that over 70% of adults 18 years and older had at least one CVD risk 
factor, either treated or untreated. Our findings further highlight the fact that among obese 
adults, almost 14% have 3 or more risk factors for CVD and that this percent has increased 
in the past decade. Each of these CVD risk factors also contributes to increase in disability 
and morbidity (26). In a recent worldwide report, high BP and tobacco exposure were the 
top two risk factors attributable to disease and disability. High BMI and elevated glucose 
levels were numbers 6 and 7 and dyslipidemia was number 15 (26).
Multiple comorbidities are an increasing issue in health care especially among the over 65-
year old population (27,28). Among an inpatient sample of adults in the United States, 
higher costs were associated with three or more chronic conditions (29). Recent 
commentaries have debated the best method for treatment of multiple chronic conditions 
(30). Our results inform the debate by further highlighting the high prevalence of multiple 
CVD risk factors and percent that are undiagnosed, particularly among the obese population.
In recent years, declines in CVD mortality in the United States have been documented. 
Many of these declines are likely due to improvements in cardiovascular risk factors in the 
US population (31-35). Among adults with diabetes in the United States, there were 
significant declines in A1c levels, BP, and low-density cholesterol from 1999 to 2008 (31). 
A study comparing a cohort from Minnesota to the general US population found that lower 
levels of CVD risk factors partially explained lower risk of cardiovascular and heart disease 
mortality observed in the Minnesota cohort (36). Prevention and reduction of cardiovascular 
risk factors has likely contributed to the decline of cardiovascular mortality in many 
industrialized countries (37). In the United States, it is estimated that 44% of decline in 
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deaths from coronary disease was due to reductions in risk factors including cholesterol, BP, 
and smoking (38). These findings, along with the findings reported here, may indicate that 
physicians and health care providers focus on controlling CVD risk factors among adults 
who are overweight or obese.
We chose to define untreated diabetes, hypertension, and dyslipidemia based on clinical 
guidelines and recent evidence of increased levels of risk (10-13). However, these guidelines 
and recommendations are a moving target. For example, recent guidelines from the Eight 
Joint National Committee on High Blood Pressure (JNC8) recommend not starting 
medication for hypertension among adults over 60 years until BP ≥ 150/90 mmHg (39). We 
did not use this new recommendation in this analysis, because at the time of the surveys the 
recommendation was for treatment when BP was ≥ 140/90 mmHg (10). Therefore, it is 
possible that we have overestimated the prevalence of total hypertension and the prevalence 
of untreated hypertension based on this recent recommendation. Similarly, while the 
recommendations in the Third Report of the National Cholesterol Education Program Expert 
Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (ATP III) focus 
on total cholesterol with non-HDL cholesterol as a secondary target, recent studies have 
found non-HDL cholesterol to be an independent predictor of CVD risk (12,40).
The main strength of this study was the use of a nationally representative survey that 
assessed cardiovascular risk factors in a standardized method over time. The main limitation 
of this study is that this is only representative of the noninstitutionalized civilian population 
able to attend the in-person exam. Additionally, NHANES does not allow estimates at the 
subnational level.
CDC has many programs to address the reduction of cardiovascular risk factors among 
adults. The National Diabetes Prevention Program is designed to bring evidence-based 
diabetes prevention for adults at risk for diabetes to communities throughout the United 
States. (http://www.cdc.gov/diabetes/prevention/about.htm) CDC also has prevention efforts 
to prevent 1 million heart attacks and strokes over the next 5 years through the Million 
Hearts campaign (http://www.cdc.gov/features/millionhearts/index.html) and includes goals 
to reduce hypertension (http://www.cdc.gov/bloodpressure/), cholesterol levels (http://
www.cdc.gov/cholesterol/) and tobacco use (http://www.cdc.gov/tobacco/). Despite the 
improvements in CVD risk factors, obese adults have a two-fold risk compared to normal 
weight adults for many cardiovascular risk factors. These results highlight the importance of 
national prevention efforts for obesity, diabetes, hypertension, lipids, and smoking and the 
progress to date toward these prevention efforts.
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Proportion (age standardized to the 2000 US population using the following age groups: 
18-44, 45-64, and ≥65 years) of undiagnosed or untreated among total cardiovascular 
disease risk group overall and by body mass index group among adults 18 years and older, 
National Health and Nutrition Examination Surveys 1999 to 2010. *Estimates for normal 
weight participants not presented due to small sample size (<150) and relative standard error 
<35%. Normal weight = BM 18.5 to <25 kg/m2; overweight = BMI 25 to <30 kg/m2; obese 
= BMI ≥ 30 kg/m2; morbidly obese = BMI ≥ 35 kg/m Proportion of undiagnosed diabetes 
among adults with total diabetes fasting in morning exam. Proportion of untreated 
hypertension among adults with total hypertension. Proportion of untreated dyslipidemia 
among adults with total dyslipidemia. Total diabetes = self-report of diagnosis by health care 
professional or A1c level ≥ 6.5% or fasting plasma glucose ≥ 126 mg/dl Undiagnosed 
diabetes = no self-report and A1c level ≥ 6.5% or fasting plasma glucose ≥ 126 mg/dl. Total 
hypertension = self-report of antihypertensive medications or blood pressure ≥ 140/90 
mmHg; Untreated hypertension = no self-report of antihypertensive medications and blood 
pressure ≥ 140/90 mmHg. Total dyslipidemia = self-report of medications to lower 
cholesterol or non-HDL cholesterol ≥ 160 mg/dl; Untreated dyslipidemia = no report of 
cholesterol lowering medications and non-HDL cholesterol ≥ 160 mg/dl.
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Table 1
Characteristics of US adults aged 18 years and older, National Health and Nutrition 
Examination Surveys 1999 through 2010
Total 1999-2002 2003-2006 2007-2010
Sample size 33,560 10,568 10,637 12,355
Age, mean years (SE) 45.1 (0.22) 44.2 (0.32) 45.4 (0.47) 45.9 (0.33)
Age group, % (SE)
 18-44 years 51.6 (0.62) 55.2 (0.94) 51.1 (1.29) 48.9 (0.89)
 45-64 years 32.3 (0.47) 29.9 (0.84) 32.4 (0.91) 34.5 (0.64)
 65 years and older 16.1 (0.37) 14.9 (0.50) 16.6 (0.82) 16.6 (0.53)
Male, % (SE) 48.2 (0.25) 48.0 (0.46) 48.1 (0.43) 48.3 (0.40)
Race/ethnicity, % (SE)
 Mexican American or Hispanic 13.0 (0.99) 14.0 (2.02) 11.5 (1.32) 13.6 (1.74)
 Non-Hispanic black 11.3 (0.70) 10.9 (1.21) 11.5 (1.35) 11.5 (1.05)
 Non-Hispanic other 5.6 (0.36) 4.7 (0.65) 5.4 (0.46) 6.5 (0.75)
 Non-Hispanic white 70.1 (1.28) 70.4 (1.82) 71.6 (2.20) 68.4 (2.48)
Poverty Income Ratio category, % (SE)a
 <1.50 25.5 (0.75) 26.8 (1.54) 23.2 (1.20) 26.4 (1.16)
 1.50 to <3.50 32.4 (0.58) 31.7 (1.05) 34.4 (1.08) 30.9 (0.89)
 ≥3.50 42.2 (0.93) 41.5 (1.84) 42.3 (1.56) 42.6 (1.42)
Have Health Insurance, % (SE) 80.9 (0.51) 81.6 (0.89) 81.4 (1.02) 79.7 (0.74)
BMI, mean kg/m2 (SE) 28.3 (0.07) 27.9 (0.13) 28.3 (0.14) 28.5 (0.10)
BMI group, % (SE)
 18.5 to <25 kg/m2 32.0 (0.46) 33.9 (0.83) 32.0 (0.82) 30.3 (0.75)
 25 to <30 kg/m2 33.5 (0.40) 34.0 (0.79) 33.0 (0.68) 33.6 (0.60)
 ≥30 kg/m2 32.6 (0.49) 30.1 (0.89) 33.1 (0.92) 34.3 (0.71)
 ≥35 kg/m2 13.6 (0.33) 12.4 (0.66) 13.5 (0.62) 14.7 (0.45)
SE, standard error.
a
PIR missing for participants 2,880 (8% of total NHANES sample).
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Table 2
Age standardizeda prevalence (95% CI) of cardiovascular disease risk factorsb overall 
and by BMI group among adults 18 years and older, National Health and Nutrition 
Examination Surveys 1999 through 2010
1999-2002 2003-2006 2007-2010 Percentage point change from 
1999-2002 to 2007-2010, % (95% 
CI)
Total populationc
 Sample size 10,132 10,436 12,175
 Fasting sample sized 4,426 4,406 5,188
 Total diabetesd 9.4 (8.2, 10.7) 10.2 (9.0, 11.4) 11.0 (9.9, 12.2) 1.6 (0.01, 3.2)
 Undiagnosed diabetesd 3.4 (2.8, 4.0) 3.2 (2.5, 4.0) 3.7 (3.1, 4.3) 0.3 (−0.5, 1.1)
 Total hypertension 27.8 (26.2, 29.4) 28.7 (27.3, 30.1) 28.6 (27.6, 29.6) 0.8 (−1.1, 2.7)
 Untreated hypertension 10.9 (9.7, 12.1) 9.3 (8.3, 10.3) 7.3 (6.7, 7.8) −3.6 (−4.9, −2.3)
 Total dyslipidemia 41.1 (39.7, 42.5) 39.8 (38.5, 41.2) 40.4 (39.2, 41.7) −0.7 (−2.5, 1.1)
 Untreated dyslipidemia 32.5 (31.1, 33.9) 27.5 (26.3, 28.7) 26.0 (24.9, 27.0) −6.5 (−8.2, −4.8)
 Self-reported smoking 27.8 (25.8, 29.8) 30.2 (28.2, 32.1) 27.1 (25.4, 28.7) −0.7 (−3.2, 1.8)
 Moderate to heavy smoking exposure 28.6 (26.3, 30.8) 29.0 (26.8, 31.1) 26.0 (24.1, 28.0) −2.6 (−5.5, 0.3)
Normal weight
 Sample size 3,325 3,282 3,385
 Fasting sample sized 1,486 1,362 1,441
 Total diabetesd 5.1 (3.5, 6.8) 5.1 (3.4, 6.8) 5.4 (3.8, 6.9) 0.3 (−2.0, 2.5)
 Undiagnosed diabetesd 1.3 (0.7, 1.9) 1.5 (0.8, 2.2) 1.6 (0.8, 2.4) 0.3 (−0.8, 1.3)
 Total hypertension 18.7 (17.0, 20.4) 20.2 (8.6, 21.7) 19.8 (18.1, 21.6) 1.12 (−1.3, 3.5)
 Untreated hypertension 8.7 (7.5, 9.8) 8.0 (6.7, 9.3) 7.4 (6.4, 8.3) −1.3 (−2.8, 0.2)
 Total dyslipidemia 29.4 (27.8, 31.0) 26.8 (24.7, 29.0) 28.6 (27.2, 30.0) −0.8 (−.9, 1.3)
 Untreated dyslipidemia 23.5 (21.7, 25.2) 18.7 (16.8, 20.6) 19.0 (17.3, 20.7) −4.5 (−6.9, 22.1)
 Self-reported smoking 31.5 (28.0, 35.1) 33.6 (31.1, 36.3) 29.5 (26.7, 32.2) −2.1 (−6.5, 2.4)
 Moderate to heavy smoking exposure 32.4 (28.6, 36.2) 32.3 (29.6, 35.0) 28.8 (25.9, 31.6) −2.0 (−5.3, 1.2)
Overweight
 Sample size 3,525 3,494 4,102
 Fasting sample sized 1,548 1,451 1,768
 Total diabetesd 8.2 (6.3, 10.0) 7.6 (6.2, 9.0) 8.2 (6.5, 9.9) 0.01 (−2.5, 2.5)
 Undiagnosed diabetesd 2.9 (2.1, 3.7) 2.6 (1.7, 3.6) 3.1 (2.3, 3.9) 0.2 (−0.9, 1.4)
 Total hypertension 26.7 (24.4, 29.1) 27.3 (25.2, 29.4) 26.4 (24.7, 28.0) −0.4 (−3.2, 2.5)
 Untreated hypertension 11.4 (9.4, 13.4) 9.7 (8.1, 11.3) 7.2 (6.2, 8.2) −4.2 (−6.5, 21.9)
 Total dyslipidemia 47.6 (45.6, 49.7) 45.8 (43.2, 48.3) 44.2 (42.5, 46.0) −3.4 (−6.3, 20.5)
 Untreated dyslipidemia 38.1 (35.5, 40.7) 33.6 (31.5, 35.8) 30.6 (29.0, 32.3) −7.5 (−10.5, 24.5)
 Self-reported smoking 28.0 (26.0, 30.1) 29.2 (26.7, 31.6) 27.4 (25.1, 29.8) −0.3 (−3.4, 2.8)
 Moderate to heavy smoking exposure 27.7 (25.4, 29.9) 27.8 (25.0, 30.5) 26.0 (23.7, 28.3) −1.7 (−4.9, 1.6)
Obese
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1999-2002 2003-2006 2007-2010 Percentage point change from 
1999-2002 to 2007-2010, % (95% 
CI)
 Sample size 3,083 3,465 4,476
 Fasting sample sized 1,294 1,492 1,876
 Total diabetesd 16.0 (13.01, 18.8) 17.4 (14.8, 20.0) 18.5 (16.6,20.4) 2.5 (−0.9, 5.9)
 Undiagnosed diabetesd 6.2 (4.8, 7.7) 5.8 (4.1, 7.4) 6.6 (5.2, 8.0) 0.4 (−1.6, 2.4)
 Total hypertension 37.5 (35.1, 39.9) 38.4 (36.2, 40.6) 35.66 (37.3, 40.1) −1.9 −4.6, 0.9)
 Untreated hypertension 12.5 (10.2, 14.9) 10.4 (9.1, 11.8) 7.96 (6.9, 9.0) −4.6 (−7.1, 22.0)
 Total dyslipidemia 50.7 (48.4, 53.0) 48.7 (46.2, 51.2) 49.74 (47.4, 52.0) 0.9 (−4.1, 2.3)
 Untreated dyslipidemia 40.2 (37.8, 42.6) 32.1 (29.8, 34.9) 30.55 (28.5, 32.6) −9.6 (−12.5, 26.6)
 Self-reported smoking 24.8 (22.1, 27.4) 27.5 (25.0, 30.0) 24.5 (22.9, 26.1) −0.3 (−3.4, 2.8)
 Moderate to heavy smoking exposure 25.1 (22.5, 27.9) 26.6 (24.1, 29.0) 23.1 (21.3, 25.0) −2.0 (−5.3, 1.2)
Morbidly obese
 Sample size 1,257 1,422 1,939
 Fasting sample sized 530 632 797
 Total diabetesd 21.6 (16.7, 26.6) 23.5 (18.9, 28.1) 23.2 (19.9, 26.5) 1.6 (−4.3, 7.4)
 Undiagnosed diabetesd 7.6 (5.1, 10.2) 8.5 (5.1, 12.0) 9.3 (6.6, 12.0) 1.7 (−2.0, 5.4)
 Total hypertension 42.4 (28.5, 46.3) 44.5 (41.6, 47.4) 44.4 (42.1, 46.7) 1.98 (−2.5, 6.4)
 Untreated hypertension 12.0 (8.7, 15.3) 9.9 (8.2, 11.7) 7.4 (5.5, 9.0) −2.6 (8.3, 20.8)
 Total dyslipidemia 46.6 (43.4, 49.8) 47.3 (44.3, 50.3) 47.7 (44.6, 50.9) 1.1 (−3.3, 5.6)
 Untreated dyslipidemia 36.3 (33.0, 39.7) 29.7 (26.7, 32.8) 27.7 (25.0, 30.4) −6.6 (−11.1, −2.1)
 Self-reported smoking 22.4 (19.3, 25.6) 24.6 (21.0, 28.2) 23.0 (20.6, 25.3) 0.5 (−3.3, 4.4)
 Moderate to heavy smoking exposure 22.6 (18.7, 26.5) 24.1 (20.5, 27.6) 21.4 (19.0, 23.8) −1.2 (−5.8, 3.3)
a
Estimates among fasting participants in morning examination only, age standardized to the 2000 U.S. population using the following age groups: 
18-44, 45-64, and ≥65 years.
b
CVD risk factors included: total diabetes (self-report of diagnosis by health care professional or A1c level ≥ 6.5% or fasting plasma glucose ≥ 126 
mg/dL); undiagnosed diabetes (no self report of diabetes and A1c level ≥ 6.5% or fasting plasma glucose ≥ 126 mg/dL); total hypertension (self-
report of anti-hypertensive medications or blood pressure ≥ 140/90 mmHg); untreated hypertension (no self-report of anti-hypertensive medications 
and blood pressure ≥ 140/90 mmHg); total dyslipidemia (self-report of medications to lower cholesterol or non-HDL cholesterol ≥ 160 mg/dL); 
untreated dyslipidemia (no self-report of medications to lower cholesterol and non-HDL cholesterol ≥ 160 mg/dL); self-reported smoking (18-19 
years report of tobacco or nicotine use in past 5 days, 20 years and older report of smoking at least 100 cigarettes and currently smoking) and 
moderate to heavy smoking exposure (cotinine levels ≥ 10 ng/mL).
c
Total population includes participants with BMI< 18.5 kg/m2.
d
Total and undiagnosed diabetes estimates only among fasting participants in morning exam.
Normal weight = BMI 18.5 to <25 kg/m2; overweight = BMI 25 to <30 kg/m2; obese = BMI ≥ 30 kg/m2; morbidly obese = BMI ≥ 35 kg/m2.
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Table 3
Age standardized prevalencea (95% CI) of number of cardiovascular disease (CVD) risk 
factorsb by BMI group among adults 18 years and older, National Health and Nutrition 
Examination Surveys 1999 through 2010
1999-2002 2003-2006 2007-2010 Percentage point change from 1999-2002 to 
2007-2010, % (95% CI)
Totalc
 Sample size 4,426 4,406 5,188
 1 CVD risk factor 38.4 (36.3, 40.6) 37.8 (36.0, 39.6) 37.8 (35.6, 39.9) −0.6 (−3.6, 2.4)
 2 CVD risk factors 25.0 (23.0, 27.1) 22.3 (20.6, 24.0) 21.1 (19.5, 22.7) −3.9 (−6.5, 21.3)
 ≥3 CVD risk factors 6.6 (5.6, 7.6) 8.3 (7.1, 9.4) 7.7 (6.9, 8.6) −1.1 (−0.2, 2.4)
Normal weight
 Sample size 1,484 1,361 1,441
 1 CVD risk factor 38.1 (35.6, 40.6) 39.0 (36.4, 41.5) 36.2 (32.6, 39.9) −1.8 (−6.3, 2.6)
 2 CVD risk factors 18.8 (16.0, 21.6) 18.7 (16.5, 21.0) 16.7, (13.9, 19.4) −2.2 (−6.0,1.7)
 ≥3 CVD risk factors 3.5 (1.9, 5.1) 3.5 (2.1, 4.9) 3.2 (2.4, 4.0) −0.3 (−2.1, 1.4)
Overweight
 Sample size 1,548 1,450 1,766
 1 CVD risk factor 40.7 (37.2, 44.2) 39.9 (37.2, 42.6) 41.8 (38.5, 45.0) 1.1 (−3.7, 5.8)
 2 CVD risk factors 27.4 (24.3, 30.5) 21.3 (18.8, 23.9) 22.3 19.8, 24.8) −5.1 (−9.1, −1.2)
 ≥3 CVD risk factors 6.0 (4.8, 7.2) 7.0 (5.3, 8.7) 5.5 (4.6, 6.5) −0.4 (−1.9, 1.1)
Obese
 Sample size 1,294 1,492 1,876
 1 CVD risk factor 37.1 (33.5, 40.7) 34.9 (31.1, 38.7) 36.0 (33.5, 38.5) −1.1 (−5.5, 3.2)
 2 CVD risk factors 31.0 (27.3, 34.6) 27.1 (23.2, 30.9) 25.1 (22.4, 27.7) −5.9 (−10.4, −1.5)
 ≥3 CVD risk factors 10.4 (8.4, 12.4) 14.0 (12.3, 16.3) 13.5 (11.9, 15.1) 3.1 (0.5, 5.6)
Morbidly obese
 Sample size 530 632 797
 1 CVD risk factor 35.7 (30.6,40.9) 35.3 (29.1, 41.5) 30.3 (26.3, 34.4) −5.4 (−11.9, 1.1)
 2 CVD risk factors 31.3 (26.5, 36.1) 27.7 (20.7, 34.8) 26.7 (22.6, 30.7) −4.6 (−10.8, 1.7)
 ≥3 CVD risk factors 11.2 (7.4, 15.1) 16.5 (12.8, 20.2) 16.5 (13.9, 19.2) 5.3 (0.7, 10.0)
a
Estimates among fasting participants in morning examination only, age standardized to the 2000 U.S. population using the following age groups: 
18-44, 45-64, and ≥ 65 years.
b
CVD risk factors included: total diabetes (self-report of diagnosis by health care professional or A1c level ≥ 6.5% or fasting plasma glucose ≥ 126 
mg/dl); total hypertension (self-report of antihypertensive medications or blood pressure ≥ 140/90 mmHg); total dyslipidemia (self-report of 
medications to lower cholesterol or non-HDL cholesterol ≥ 160 mg/dl); and self-reported smoking.
c
Total population includes participants with BMI<18.5 kg/m2 (fasting participants with BMI<18.5 kg/m2 in morning exam: 1999-2002, n = 98; 
2003-2006, n = 101 2007-2010, n = 103).
Normal weight = BMI 18.5 to <25 kg/m2; overweight = BMI 25 to <30 kg/m2; obese = BMI ≥ 30 kg/m2; morbidly obese = BMI ≥ 35 kg/m2.
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